Logo
Purasomes SGC100+ Skin Glow Complex

Purasomes SGC100+ Skin Glow Complex

Purasomes

Professional exosome skin treatment
  • Developed and manufactured by Dermoaroma Italy S.R.L., a company specialising in exosome Based and regenerative aesthetic formulations.
  • Utilises AMPLEX Plus technology combining organic colostrum Derived exosomes, growth factors, hyaluronic acid, plant stem cells, antioxidants and peptides for professional cosmetic and aesthetic use.
  • Distributed through professional aesthetic channels such as DermaFocus and DD Group in accordance with local regulatory frameworks governing exosome and growth Factor based products.
Exosome-based skin glow and depigmenting complex for microneedling

Description

Purasomes SGC100+ Skin Glow Complex is an advanced exosome-powered treatment designed to reset melanin production and rebuild a flawless, luminous complexion. Targeting dull, damaged and hyperpigmented skin, it combines 20 billion organic colostrum-derived exosomes, 20 functional growth factors, dual molecular weight hyaluronic acid, plant-derived seed stem cells, antioxidants and peptides within the AMPLEX Plus technology platform. Clinically proven to significantly reduce melanophilin production, SGC100+ decreases the formation of pigmentation, reduces age spots and post-inflammatory hyperpigmentation, refines pores, improves overall skin tone and revitalises the skin for radiance and vitality. By promoting cell turnover, angiogenesis and skin healing while decreasing inflammation and free radicals, it creates a long-lasting protective antioxidant barrier against sun-induced damage and helps restore a brighter, more even and radiant complexion. The complex is delivered to the dermis via microneedling in a series of professional in-clinic treatments.

Bnefits

  • Resets melanin production pathways by significantly reducing melanophilin, decreasing pigment formation and helping prevent new hyperpigmentation.
  • Reduces the appearance of scars and skin lesions while fading age spots and post-inflammatory hyperpigmentation.
  • Improves overall skin tone, rebuilding a more harmonised, even and flawless complexion.
  • Revitalises dull, damaged skin for increased radiance, vitality, brightness and luminosity.
  • Minimises pores and refines skin texture for a smoother, clearer surface.
  • 20 billion exosomes and 20 growth factors promote cell turnover, support angiogenesis, facilitate skin healing and reduce inflammation, a key driver of skin ageing.
  • Dual molecular weight hyaluronic acid hydrates the skin at multiple levels, helping to maintain a healthy moisture balance and barrier function.
  • Plant-derived seed stem cells, antioxidants and peptides provide strong antioxidant protection, reducing free radicals and creating a long-lasting protective barrier against sun radiation.
  • Acts as an excellent skin primer for energy-based treatments and supports post-procedure recovery; can be combined with polynucleotides to fully optimise results.

Indications

  • Dull, lacklustre skin in need of brightening and revitalisation.
  • Hyperpigmented skin, including age spots and post-inflammatory hyperpigmentation.
  • Uneven skin tone and poor skin clarity.
  • Mild scars and skin lesions where improved texture and tone are desired (at the clinician’s discretion).
  • Enlarged pores and rough or irregular skin texture.
  • Patients seeking non-surgical, regenerative brightening treatments delivered via microneedling.
  • Use as a priming and recovery-supportive treatment around energy-based procedures such as lasers and radiofrequency, and in combination with polynucleotides.

Composition

  • 20 billion organic colostrum-derived exosomes.
  • 200 mg of 20 functional growth factors.
  • 50 mg high molecular weight hyaluronic acid (HMW HA, approx. 1100–1400 kDa).
  • 55 mg low molecular weight hyaluronic acid (LMW HA, approx. 80–100 kDa).
  • Plant-derived seed stem cells (including pomegranate-derived stem cell actives as described by the manufacturer).
  • Antioxidants providing protection against free radicals and oxidative stress.
  • Peptides supporting skin regeneration, structure and barrier function.
  • Proprietary AMPLEX Plus technology vehicle and excipients suitable for professional dermal application.

Formulation

  • Sterile, ready-to-use exosome and growth-factor rich solution for topical delivery via microneedling.
  • Multi-patented AMPLEX Plus technology combining exosomes, growth factors, plant stem cells, dual-weight hyaluronic acid, antioxidants and peptides.
  • Non-crosslinked, low-viscosity fluid intended for percutaneous delivery into the dermis using microneedling (not for direct needle injection).

Packaging

  • Typically supplied as 3 x 5 ml vials of Purasomes SGC100+ Skin Glow Complex in a professional clinic pack (pack size may vary by distributor).
  • Each glass vial contains a single-use or session-appropriate volume of solution for microneedling over the indicated treatment area.
  • Outer carton and vial labels include product name, batch number and expiry date for professional traceability.

Usage

  • For professional use only; treatment must be performed by trained medical or aesthetic practitioners experienced in microneedling and regenerative protocols.
  • Assess the patient’s skin, pigmentation pattern, medical history and suitability for exosome-based microneedling treatments.
  • Cleanse the treatment area thoroughly to remove makeup, oil and impurities; disinfect according to clinic protocol.
  • Using a suitable microneedling device (pen or stamp), select an appropriate needle depth for the treatment area and patient skin type, and create uniform micro-channels over the target zones.
  • Apply Purasomes SGC100+ Skin Glow Complex evenly to the skin during or immediately after microneedling, working the solution into the micro-channels to enhance penetration.
  • Gently massage any residual product into the skin until absorbed, avoiding excessive friction or trauma.
  • A typical protocol consists of a series of three to five treatments performed approximately every four weeks, adjusted based on clinical response and the severity of pigmentation or dullness.
  • Instruct patients to avoid sun exposure during the healing phase and to apply broad-spectrum sunscreen regularly; advise them to avoid tanning beds and unnecessary UV exposure between sessions.
  • Recommend a gentle skincare routine post-procedure, avoiding strong acids, retinoids or other potentially irritating actives for several days after treatment.
  • Use Purasomes SGC100+ as a standalone microneedling treatment, as a primer prior to energy-based procedures, as a recovery aid afterwards, or in combination protocols with polynucleotides for enhanced results, following manufacturer and clinic guidelines.

Contraindications

  • Known hypersensitivity or allergy to any component of the formulation (e.g. hyaluronic acid, plant-derived stem cell components, peptides, antioxidant agents or other excipients).
  • Active skin infections (bacterial, viral or fungal), open wounds, ulcerations or unhealed lesions in the proposed treatment area.
  • Inflammatory skin diseases or acute flares (e.g. active eczema, psoriasis, severe dermatitis or rosacea) in the treatment zone where microneedling is contraindicated.
  • History of keloid or hypertrophic scarring in areas to be treated, where microneedling and regenerative stimulation are considered high risk by the treating clinician.
  • Recent use of systemic isotretinoin within a timeframe that contraindicates microneedling or resurfacing procedures according to current guidelines.
  • Severe uncontrolled systemic disease, immunosuppression or active skin malignancy in the treatment area where regenerative or stimulating therapies are inappropriate.
  • Patients taking anticoagulant or antiplatelet medications with a bleeding risk deemed unacceptable for microneedling by the treating physician.
  • Pregnancy and breastfeeding unless a suitably qualified clinician decides otherwise in accordance with local regulations and available safety data.
  • Any general contraindication to microneedling or exosome-based treatments identified during medical assessment.

Adverse Effects

  • Expected transient effects associated with microneedling such as redness (erythema), mild swelling, warmth, tightness and pinpoint bleeding immediately after treatment.
  • Short-term dryness, flaking or sensitivity during the post-treatment healing period.
  • Risk of post-inflammatory hyperpigmentation or, rarely, hypopigmentation, particularly in darker phototypes or if aftercare and sun protection instructions are not followed.
  • Potential infection or folliculitis if aseptic technique is not adequately maintained or if the patient picks or scratches the treated area while healing.
  • Uncommon allergic or idiosyncratic reactions to one or more ingredients (e.g. plant-derived stem cells, peptides, antioxidants or vehicle components).
  • Very rare risk of prolonged erythema, irritation, textural changes or scarring if treatment is performed on contraindicated skin or with inappropriate technique or settings.

Storage Conditions

  • Store vials in their original packaging in a cool, dry place at controlled room temperature as specified by the manufacturer.
  • Protect from direct sunlight, high temperatures and freezing conditions.
  • Keep vials upright and tightly closed until use; do not use if the vial, closure or packaging is damaged or if the solution appears discoloured or otherwise altered.
  • Use each vial for a single patient session according to local infection-control policy and do not reuse any remaining product between patients.
  • Keep out of reach of children and unauthorised persons; for professional use only.

Duration

Each microneedling session with Purasomes SGC100+ typically takes around 20\u201340 minutes depending on the size of the area treated. A standard course involves three to five sessions performed at four-week intervals, with further maintenance sessions scheduled according to patient needs and clinical judgement.

Onset

Initial improvements in radiance, brightness and overall glow may be visible within weeks of starting treatment, with clinically significant reductions in pigmentation and improved tone, texture and luminosity developing over the full course of three to five sessions and subsequent skin turnover cycles.

Browse more Professional exosome skin treatment

Top Treatments

Top Cities in the UK